Merck KGaA family says unreservedly behind the pharma unit
DARMSTADT, Germany (Reuters) – The family behind Germany’s Merck KGaA said it was...
Read More
Author: Reuters
EU food safety body tells states to keep eye out for insecticide after scare
BRUSSELS (Reuters) – The European Union’s food safety watchdog urged member states on...
Read MoreSouth Africa gold producers, gold miners reach silicosis settlement
JOHANNESBURG (Reuters) – South African gold producers reached a class action settlement on Thursday with law firms representing thousands of miners who contracted the fatal lung diseases silicosis and tuberculosis, the...
Read More
Roche wins reprieve as Novartis biosimilar delayed in U.S.
By Ben Hirschler and Michael Shields LONDON/ZURICH (Reuters) – Roche has won a reprieve from...
Read More
World food price index little changed in April versus March: U.N. FAO
ROME (Reuters) – World food prices edged marginally higher in April from March, with the...
Read More
Iowa passes ‘fetal heartbeat’ abortion ban, most restrictive in U.S.
By Barbara Goldberg (Reuters) – Iowa’s Republican-controlled legislature passed the...
Read More‘DES daughters’ with rare cancer continue to face higher death rates
By Gene Emery (Reuters Health) – Women who were exposed to the synthetic estrogen diethylstilbestrol (DES) in utero, and who subsequently developed a rare type of vaginal and cervical cancer, continue to face a higher rate...
Read MoreMore sauna visits tied to lower risk of stroke
By Lisa Rapaport (Reuters Health) – Middle-aged adults who escape to a sauna every chance they get to relax may have new reason to take this time to unwind – a Finnish study suggests a regular sauna habit is...
Read MoreEven brief particle pollution spikes tied to respiratory infections
By Lisa Rapaport (Reuters Health) – People may be more likely to develop acute lower respiratory infections after even brief increases in air pollution, and babies and toddlers are especially vulnerable, a U.S. study...
Read More
CDC reports one death from E. coli outbreak linked to romaine lettuce
(Reuters) – The Centers for Disease Control and Prevention said on Wednesday one person from...
Read More
WHO says unprecedented dengue outbreak hits La Reunion
GENEVA (Reuters) – The French overseas territory of La Reunion is experiencing an...
Read MoreSeatbelts may protect against severe liver injury in car crashes
By Mary Gillis (Reuters Health) – Wearing a seatbelt may not prevent liver injuries in a car crash, but it could lessen their severity and make a major difference in the accident’s consequences and costs, researchers...
Read More
Trump administration sued over family-planning program shift
By Nate Raymond (Reuters) – Two organizations that support birth control filed lawsuits on...
Read More
President Trump wants to go further on drug prices: HHS Secretary
(Reuters) – Health and Human Services Secretary Alex Azar on Wednesday said President Donald...
Read MoreMigraine drug delay would compound Teva’s troubles
By Steven Scheer and Tova Cohen TEL AVIV (Reuters) – Teva Pharmaceutical Industries is counting on its new migraine treatment to haul it out of the doldrums. But a possible delay in U.S. approval and looming pricing battle...
Read More
Breast cancer screening failure may have shortened 270 lives in England
By Estelle Shirbon LONDON (Reuters) – As many as 270 women in England may have died...
Read More
Too many cancer drugs? Crowded market gives investors pause
By Ben Hirschler LONDON (Reuters) – In London’s world-famous Great Ormond Street...
Read MoreAccounting concerns wipe $6 billion off Samsung BioLogics market value
By Joyce Lee SEOUL (Reuters) – South Korean biotech drug manufacturer Samsung BioLogics Co Ltd <207940.KS> lost almost $6 billion in market value on Wednesday in its biggest intra-day share drop, after the...
Read More
Ecstasy therapy may help service veterans suffering PTSD
By Kate Kelland (Reuters) – Combining intensive psychotherapy with a pure form of the party...
Read More
U.S. approves Novartis cell therapy for lymphoma
By Deena Beasley (Reuters) – U.S. regulators approved Novartis’ cell therapy Kymriah...
Read More